Professional Year 3


First Semester
Second Semester
PHPP-505 Therapeutics V                       

3 (3-0)


Therapeutics VII                      3 (3-0)
PHPP-506 Therapeutics VI

3 (3-0)


Therapeutics VIII 3 (3-0)
PHPP-500 IPPE - III 1 (0-1) PHPP-509 Seminar 1 (0-1)
PHPP-501 Pharmacogenetics/Pharmacogenomics 2 (2-0) PHPP-511 Pharmacoeconomics 2 (1-1)
PHPP-502 Pharmacy Law  2 (2-0) PHPP-515 Applied Therapeutics IV 1 (0-1)
PHPP-504 Pharmacy Management and Administration    2 (1-1) PHPP-516 Medication Therapy Management    3 (2-1)
PHPP-510 Pharm. D. Research 3 (0-3) PHPP-520 IPPE Community 4 (0-4)
PHPP-513 Applied Therapeutics III  1 (0-1)










The first semester provides 17 hours of academic credit and consists of eight required courses. The following required courses are covered by this contract.

  • Therapeutics V, PHPP-505. This course is a continuation of Therapeutics IV and is designed to develop the student's ability to apply principles and concepts of clinical therapeutics to the care of patients with specific illnesses. The primary focus of the course will be the therapeutic management of several disease states including, oncology, autoimmune disorders, endocrinology and hematological disorders and to design Nutritional Plans. The etiology and pathophysiology of these diseases will be presented to the extent needed to thoroughly understand the therapeutic management. Emphasis will be placed on selection and evaluation of rational drug therapy, design of effective therapeutic regimens, and clinical monitoring of drug response using appropriate laboratory and physical measures. Credit 3 (3-0)
  • Therapeutics VI, PHPP-506. The focus of this course is the pathophysiology and pharmacotherapy of neurological and psychological disorders.  Students are expected to review all materials from lecture along with the required readings. The course will be taught using a mixture of lecture-based and team-based learning class sessions. Credit 3 (3-0)
  • IPPE III, PHPP-500. The goal of this Introductory Pharmacy Practice Experience III (PHPP-500) is to allow hands-on experience to the student under the close supervision of a pharmacist in the various sections of the Department of Pharmaceutical Care. Credit 1 (0-1)
  • Pharmacogenetics/Pharmacogenomics, PHPP-501. This course will introduce emerging information regarding genetic variation in the human genome and how this information can be applied to the fundamental precepts of pharmacokinetics (absorption, metabolism, distribution, and excretion) and pharmacodynamics as well as applied pharmacotherapy. Moreover, the impact of genetic variation on disease susceptibility and next generation drug discovery and development will be explored. Finally, important ethical considerations when testing for and applying clinically-relevant genetic information will be discussed. Credit 2 (2-0)
  • Pharmacy Law, PHPP-502This course will focus on the most significant regulations pertaining to the practice of pharmacists in Saudi Arabia. Such regulations have been compiled from published rules and declarations by the Royal Authority, S-FDA, the Ministry of Health, the Saudi Commission for Health Specialists, and the GCC Guidance. The course will also provide a brief review of professional ethics and of the American Federal law that may have partially influenced the enactment of these regulations. Credit 2 (2-0)
  • Pharmacy Management and Administration, PHPP-504. This course will focus on management principles and skills that the pharmacist should learn. The course will present the management principles and will discuss implementation with an interactive selected management project under the supervision of the expert faculty or administrators in the university, hospital or community. Credit 2 (1-1)
  • Pharm.DResearch, PHPP-510. This course along with the designated research faculty will guide the student through a step by step on how to conduct the approved research protocol submitted at the end of  (PHPP 410). This effort is expected to be culminated by a final report within an eight months period from enrollment, namely by the end of the second semester. Any extension beyound this time period needs to be approved by the research faculty followed by an endorsement from the Student Research Unit. The satisfactory conclusion of the research project may not extend beyond the end of the summer of the academic year. The course is considered fulfilled only upon the acceptance of the Research Unit of the final report as meeting all academic and scholastic standards as stated in the syllabus. Credit 3 (0-3)
  • Applied Therapeutics III, PHPP-513This course is the practical application of P3 Therapeutic courses. Students will be provided with patient cases and apply therapeutic knowledge in order to construct therapeutic plans according to the latest practice guidelines. This will reinforce and enhance the learning experience in the didactic Therapeutics courses. Expand knowledge and understanding of some of the disease states and drug therapy covered in case discussion are parts of the of the course’s aims. This course will also refine communication skills with faculty, other pharmacy students, and perhaps pharmacy residents. It will also enrich critical thinking and evidence based implementation for students. 

In addition, written communication skills should be enhanced as well as the ability to organize patient data and identify potential problems. The challenge of presenting to a group and taking questions from others is an important part of student growth. Credit 1 (0-1)



The second semester of the year 3 consist of 17 hours of academic credit and consists of seven required courses.

  • Therapeutics VII, PHPP-507. The specific topics addressed in this course complement those presented in Therapeutics I-VI. However, such topics are discussed in more depth especially when it comes to distinct populations in our society such as women, children and geriatric patients and diseases that affect specific age groups. Credit 3 (3-0)
  • Therapeutics VIII, PHPP-508. This course will incorporate didactic lectures to establish a basic understanding of critical care topics.  It will also utilize group discussion of primary (research articles) and secondary (reviews and/or guidelines) literature of selected critical care topics to enhance the students’ knowledge in each area.  The course will provide the student with an advanced understanding of how results of clinical trials impact patient care.  Students will also advance skills necessary to evaluate and present primary literature. Credit 3 (3-0)
  • Seminar, PHPP-509This course is designed to help students develop skills necessary for answering clinical and controversial questions that related to the practice. These skills include; literature search, critical appraisal for published articles and selection of the strongest evidence in support of the evidence based practice approach. The student will be randomly assigned one of the listed topics in this syllabus and prepares his/her seminar under the supervision of the topic content expert faculty. Credit 1 (0-1)
  • Pharmacoeconomics, PHPP-511. This course is designed to provide students with core knowledge, skills and abilities associated with basic principles of pharmacoeconomic. Pharmacoeconomic is the description and analysis of the costs of drug therapy to health care systems and society. Pharmacoeconomic studies identify, measure, and compare the costs and consequences of pharmaceutical products and services. Credit 2 (1-1)
  • Applied Therapeutics IV, PHPP-515. This course is an extension of the P1, P2, and P3 therapeutic courses. Students will be provided with patient cases and apply therapeutic knowledge in order to solve problems. This will reinforce and enhance the learning experience in the didactic Therapeutics courses. Increased knowledge of some of the disease states and drug therapy covered in lecture is one of this course’s aims. Communication skills with faculty, other pharmacy students, and perhaps pharmacy residents will be refined.

    Because this course is an extension of the IPPE courses and is based on Therapeutics VII and VIII being concurrently taught during the same semester, the student must review the Therapeutics VII and VIII material prior to preparing their respective case presentations. Students are expected to be able to answer questions when challenged by other students, residents, or faculty members. Credit 1 (0 – 1)

  • Medication Therapy Management, PHPP-516. Medication therapy management services are used to optimize a patient’s drug therapy and prevent adverse drug events, hospitalizations, and death. This course explores the area of medication therapy management services and medication use by patients and health professionals from a social systems perspective.  It emphasizes information about a) the background and concepts of MTM, b) common drug therapy problems found in patients with various disease states, c) medication adherence issues, d) pharmacist-physician collaboration, and e) documentation of MTM services. This course is not designed to make you an expert in Medication Therapy Management, nor totally prepare you to start up your own MTM practice after graduation. It is designed, however, to give you a good foundation on the practice and theory of Medication Therapy Management, give you a better understanding of various MTM practice settings, and provide you with practical MTM activities (during Recitation) to make you more comfortable with the MTM process. Credit 3 (2 – 1)
  • IPPE Community, PHPP-520. This is an eight weeks, 192 practical hours course. Each student will be assigned to a community pharmacy for eight weeks training period. The student will function as a trainee under the immediate supervision of a licensed pharmacist. He/she should carry out all the professional functions and services the pharmacist assigns him/her to render within the community pharmacy. Credit 4 (0-4)

College of Pharmacy - KSAU-HS © 2012 - 2022